Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Hodgkin Disease 24Lymphoma 21Testicular Neoplasms 6Teratoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Non-Hodgkin 5Endodermal Sinus Tumor 5Testicular Germ Cell Tumor 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4HIV Infections 4Carcinoma, Embryonal 4Acquired Immunodeficiency Syndrome 4Sarcoma, Kaposi 3Ovarian Neoplasms 3Ovarian Germ Cell Cancer 3Head and Neck Neoplasms 3Teratoma, Testicular 2Seminoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Neoplasm Metastasis 2Cardiotoxicity 2Carcinoma, Squamous Cell 2Carcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Mediastinal Neoplasms 1

Interventions

Cyclophosphamide 16Vincristine 12Doxorubicin 11Radiotherapy 10Etoposide 9Prednisone 8Peripheral Blood Stem Cell Transplantation 8VAP-cyclo protocol 6Filgrastim 6Rituximab 5Mitoxantrone 5Melphalan 5Cytarabine 5Carmustine 4Bleomycin 4Prednisolone 3Methylprednisolone 3Methotrexate 3Idarubicin 3liposomal amphotericin B 2aldesleukin 2Therapeutics 2Psychiatric Rehabilitation 2Levofloxacin 2Leucovorin 2Interferon-alpha 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Epoetin Alfa 2Early Intervention, Educational 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Large-Cell, Immunoblastic × Bleomycin × Clear all
NCT00002835 2018-11-15

Combination Chemotherapy in Treating Patients With Lymphoma

M.D. Anderson Cancer Center

Phase 3 Completed
116 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00002565 2018-11-14

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

M.D. Anderson Cancer Center

Phase 3 Completed
61 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00003815 2013-09-17

Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00005867 2013-06-26

Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Completed
310 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡